NIH-funded research R01 grant

How cell-specific DNA elements may drive Alzheimer's disease and aging

Official title: Identification and Characterization of Cell-Specific Transposable Elements Implicated on Alzheimer Disease and Healthy Aging

Funded at Washington University · NIH-11371087 · Data updated 2026-11-12

Researchers are studying how certain DNA elements that can move around the genome contribute to Alzheimer’s disease and aging, using samples from adults and people with related risk factors.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionWashington University
NIH-funded
Lab location1 site (Saint Louis, United States)
Project startAugust 15, 2022
Project endJune 30, 2027
Funding year2026
Award (this year)$1,809,944
NIH project number5R01AG078964-05
Project IDNIH-11371087 on NIH RePORTER

Who could benefit from this research

Could help

Adults with Alzheimer’s disease pathology or risk factors, including APOE variants and mutations in APP, PSEN1, PSEN2, or TREM2/MS4A.

Less likely to help

Individuals without AD pathology or risk variants may have limited direct benefit from this specific genetic study.

What this research studies

This project will look at brain tissue, directly converted neurons, and stem-cell–derived microglia to map cell-specific genetic elements linked to Alzheimer’s. By combining new genomic techniques with patient samples, scientists hope to identify how these elements alter chromatin and gene activity in different brain cells. The goal is to uncover mechanisms by which these elements influence disease risk and progression, and to explore how editing or targeting these elements might affect disease pathways.

Why it matters

Potential benefit: Understanding these cell-specific mechanisms could lead to new strategies for preventing or slowing Alzheimer's by targeting the underlying genetic regulators.

How similar studies have gone: Previous work shows cell-type differences in Alzheimer’s genetics; this study extends to transposable elements with human brain tissues and cell models.

Where this research is happening

  • Washington University
    Saint Louis, United States
    Active

Researchers

  • Principal investigator: Cruchaga, Carlos — Washington University
  • Study coordinator: Cruchaga, Carlos

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.